Activity Provided By:

ACHL

Breaking the Cycle: The Role of Microbiota-Based Biotherapies in the Reduction of Recurrent Clostridioides difficile

Overview / Abstract:	Drs. Paul Feuerstadt, Sahil Khanna, Teena Chopra and Caterina Oneto convened at annual gastroenterology and infectious disease congresses to discuss clinical scenarios and best practices to manage recurrent Clostridioides difficile (C. difficile) infections; this activity chronicles their discussions. Tune in for updates on risk factors and prevention strategies for recurrent infection, as well as up-and-coming treatment options such as cutting-edge microbiota restoration therapies as discussed through a series of real-world patient cases.
Expiration	Nov 30, 2023
Discipline(s)	Physician CME, Physician Assistant CME
Format	Webinar / Webcast / Video
Credits / Hours	1.0
Accreditation	ACCME, ACPE
Is This Activity Certified for "Live" Credit?	YES
Presenters / Authors / Faculty	Teena Chopra, MD, MPH Professor of Medicine, Division of Infectious Diseases Corporate Medical Director, Infection Prevention, Epidemiology and Antibiotic Stewardship Detroit Medical Center Wayne State University Director, Infection Prevention Epidemiology and Antibiotic Stewardship Vibra Hospital Detroit, MI Paul Feuerstadt MD, FACG, AGAF Assistant Clinical Professor of Medicine Yale University School of Medicine Gastroenterology Center of Connecticut Hamden, CT Sahil Khanna, MBBS, MS, FACG Professor of Medicine Gastroenterology and Hepatology Mayo Clinic Rochester, MN Caterina Oneto, MD Clinical Assistant Professor, Gastroenterology NYU Grossman School of Medicine New York University Langone New York, NY
Sponsors / Supporters / Grant Providers	Supported by an educational grant from Ferring Pharmaceuticals, Inc. Sponsored by the Academy for Continued Healthcare Learning (ACHL).
Keywords / Search Terms	ACHL C. difficile, CME/CE/CPE, Dr. Feuerstadt, Dr. Garey, Dr. Chopra, Dr. Oneto, recurrent, infections, infectious disease, physician, pharmacists, microbiota restoration therapy, bacterial infections, clinical cases, fidaxomicin, vancomycin, IDSA/SHEA, IDWeekTM, bezlotoxumab, FMT, Clostridioides difficile, CDI, rifaximin Free CE CME Live CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map